Objective To compare the efficacy and ocular safety between bromfenac sodium hydrate ophthalmic solution eye drops and topical compound tobramycin eye drops for the treatment of postoperative inflammation and the effect on intraocular pressure in subjects who had undergone small incision lenticule extraction （SMILE）. Methods In a prospective， case control study， 30 patients （60 eyes） were treated with bromfenac sodium hydrate ophthalmic solution eye drops 2 times daily for 2 weeks， and 30 patients （60 eyes） were treated with topical compound tobramycin eye drops 4 times daily for 1 week. All subjects had undergone SMILE surgery for myopia correction. Visual quality， intraocular pressure （IOP）， corneal sensitivity， tear film break up time （BUT）， Schirmer′s Ⅱ test， corneal fluorescein staining and ocular surface disease index （OSDI） were assessed preoperatively and at 1 week， 1 month， and 3 months postoperatively. Comparisons of the variables were performed using the repeated measures analysis of variance and multiple comparison analysis with SPSS 19.0 statistical software. Results There was no significant difference between the group treated with bromfenac sodium hydrate ophthalmic solution eye drops and the group treated with compound tobramycin eye drops when uncorrected visual acuity， best corrected visual acuity， corneal sensitivity， BUT， Schirmer′s Ⅱ test， corneal fluorescein staining and OSDI were compared. The IOPcc was significantly higher in the group treated with topical compound tobramycin eye drops （15.57±2.54 mmHg） compared to the group treated with bromfenac sodium hydrate ophthalmic solution eye drops （12.51±2.45 mmHg） and the difference was statistically significant （F=45.409， P<0.05）. Conclusion Bromfenac sodium hydrate ophthalmic solution eye drops have the same anti-inflammatory effect as topical compound tobramycin eye drops and do not significantly increase IOPcc during early recovery after SMILE surgery.
刘曼丽,刘泉,王丹阳,孙远,张婷,陈仪乐,张晓颖,郑华,刘颖慧. 0.1%溴芬酸钠滴眼液在SMILE术后的早期疗效[J]. 中华眼视光学与视觉科学杂志, 2014, 16(9): 551-556.
Liu Manli,Liu Quan,Wang Danyang,Sun Yuan,Zhang Ting,Chen Yile,Zhang Xiaoying,Zheng Hua,Liu Yinghui. The short term effects of topical bromfenac sodium hydrate ophthalmic solution eye drops after SMILE. Chinese Journal of Optometry Ophthalmology and Visual science, 2014, 16(9): 551-556. DOI: 10.3760/cma.j.issn.1674-845X.2014.09.009
Soong HK， Malta JB. Femtosecond lasers in ophthalmology[J]. Am J Ophthalmol，2009，147：189-197.
[2]
Sugar A. Ultrafast （femtosecond） laser refractive surgery[J]. Curr Opin Ophthalmol，2002，13：246-249.
[3]
Vossmerbaeumer U， Jonas JB. Structure of intracorneal femtosecond laser pulse effects in conical incision profiles[J]. Graefes Arch Clin Exp Ophthalmol，2008，246：1017-1020.
[4]
Sekundo W， Kunert KS， Blum M. Small incision corneal refractive surgery using the small incision lenticule extraction （SMILE） procedure for the correction of myopia and myopic astigmatism： results of a 6 month prospective study[J]. Br J Ophthalmol，2011，95：335-339.
[5]
Vestergaard A， Ivarsen AR， Asp S， et al. Small-incision lenticule extraction for moderate to high myopia： predictability， safety， and patient satisfaction[J]. J Cataract Refract Surg，2012， 38：2003-2010.
[6]
Hjortdal JO， Vestergaard AH， Ivarsen A， et al. Predictors for the outcome of small-incision lenticule extraction for Myopia[J]. J Refract Surg，2012，28：865-871.
[7]
Ivarsen A， Asp S， Hjortdal J. Safety and complications of more than 1500 small-incision lenticule extraction procedures[J]. Ophthalmology，2014，121：822-828.
[8]
Demirok A， Ozgurhan EB， Agca A， et al. Corneal sensation after corneal refractive surgery with small incision lenticule extraction[J]. Optom Vis Sci，2013，90：1040-1047.
[9]
Dong Z， Zhou X， Wu J， et al. Small incision lenticule extraction （SMILE） and femtosecond laser LASIK： comparison of corneal wound healing and inflammation[J]. Br J Ophthalmol，2014，98：263-269.
[10]
Knorz MC， Vossmerbaeumer U. Comparison of flap adhesion strength using the Amadeus microkeratome and the IntraLase iFS femtosecond laser in rabbits[J]. J Refract Surg，2008，24：875-878.
Qi H， Hao Y， Xia Y， et al. Regression-related factors before and after laser in situ keratomileusis[J]. Ophthalmologica，2006， 220：272-276.
[13]
Ahuja M， Dhake AS， Sharma SK， et al. Topical ocular delivery of NSAIDs[J]. AAPS J，2008，10：229-241.
[14]
Waterbury LD， Silliman D， Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium[J]. Curr Med Res Opin，2006，22：1133-1140.
[15]
Cho H， Wolf KJ， Wolf EJ. Management of ocular inflammation and pain following cataract surgery： focus on bromfenac ophthalmic solution[J]. Clin Ophthalmol，2009，3：199-210.
[16]
Wang XJ， Wong SH， Givergis R， et al. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK[J]. Clin Ophthalmol，2011，5：1451-1457.
Walters TR， Goldberg DF， Peace JH， et al. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery： results of 2 randomized controlled trials[J]. Ophthalmology，2014，121：25-33.
[19]
Stewart RH， Grillone LR， Shiffman ML， et al. The systemic safety of bromfenac ophthalmic solution 0.09%[J]. J Ocul Pharmacol Ther，2007，23：601-612.
[20]
Silverstein SM， Cable MG， Sadri E， et al. Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain[J]. Curr Med Res Opin，2011，27：1693-1703.
[21]
Henderson BA， Gayton JL， Chandler SP， et al. Safety and efficacy of bromfenac ophthalmic solution （Bromday） dosed once daily for postoperative ocular inflammation and pain[J]. Ophthalmology，2011，118：2120-2127.
[22]
Donnenfeld ED， Holland EJ， Stewart RH， et al. Bromfenac ophthalmic solution 0.09% （Xibrom） for postoperative ocular pain and inflammation[J]. Ophthalmology，2007，114：1653-1662.
浙公网安备 33030202001892号